Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06781424 · ClinicalTrials.gov registry record

University of Central Florida BEEAST

A clinical trial of Biospecimen Donation and Environmental Impact, sponsored by University of Central Florida.

Recruiting
Registry status
10,000
Enrollment target
1
Study location

NCT06781424: Recruiting study of Biospecimen Donation and Environmental Impact, sponsored by University of Central Florida.

NCT06781424 is a study of Biospecimen Donation and Environmental Impact that is actively recruiting participants, run by University of Central Florida. The registered enrollment target is 10,000 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06781424, a study of Biospecimen Donation and Environmental Impact, is actively recruiting participants, sponsored by University of Central Florida.

RECRUITING
Registry status
10,000 participants
Enrollment target
1
Study location

Study Summary

Since the inception of aerospace travel, NASA has been collecting biospecimens from professional astronauts for research. With the recent growth of civilian aerospace travelers, there is a need for biospecimen banking for civilian astronauts. This protocol addresses this gap by being a biobank for civilian astronauts, their family members (to be controls) and others who are also doing travel to extreme environments (pilots, submariners).

Primary Outcome

Donated biospecimens from participants will aid in the improvement of medical aerospace research. The key research divisions are cancer, cardiovascular, immunity and pathogenesis, neuroscience, and molecular microbiology.

Study Locations (1)

Florida

  • University of Central Florida - Orlando

Trial Details

FieldValue
Enrollment Target 10,000 participants
Start Date 2025-01-13
Est. Completion 2075-01-13
University of Central Florida

91 total trials

What NCT06781424 shows while recruiting

NCT06781424 is an observational study that tracks outcomes without assigning an intervention. Its 10,000 participants enrollment target places it among the larger protocols in the corpus.

The record links to 2 conditions, with Biospecimen Donation appearing as the primary indexed condition, and to 0 interventions.

NCT06781424 reports a single indexed study location in Florida.

Frequently Asked Questions

What is clinical trial NCT06781424 about?

NCT06781424 is a clinical study titled "University of Central Florida BEEAST". Since the inception of aerospace travel, NASA has been collecting biospecimens from professional astronauts for research. With the recent growth of civilian aerospace travelers, there is a need for biospecimen banking for civilian astronauts. This protocol addresses this gap by being a biobank for c...

What is the current status of trial NCT06781424?

This trial is currently recruiting. The enrollment target is 10,000 participants. The study started on 2025-01-13. Estimated completion is 2075-01-13.

What conditions does trial NCT06781424 study?

This clinical trial studies the following conditions: Biospecimen Donation, Environmental Impact.

Who is sponsoring clinical trial NCT06781424?

This trial is sponsored by University of Central Florida, which has 91 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06781424 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Biospecimen Donation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00160771 · 10,000 participants

    Biomechanics/Motion Analysis Laboratory Data Bank

  • NCT00896935 · 10,000 participants

    Arizona Cancer Center Biospecimen Repository

  • NCT00898235 · 10,000 participants

    Collection of Samples and Clinical Data From Patients With Amyloid Diseases

  • NCT00992303 · 10,000 participants

    Collecting Tissue Samples From Patients With Cancer Undergoing Radiation Therapy and Healthy Participants

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06781424, the US trial registry maintained by the National Library of Medicine. NCT06781424 (large enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.